Clinical Trial Update: Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update on using Endostar in combination with mFOLFOX6 as first-line treatment for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)
• MFOLFOX6

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN